Clinical Background BPC-157 was introduced in 1993 and initially studied as a potential treatment for inflammatory bowel disease due to its anti-ulcer effects
Therefore, its recommended to avoid taking multiple NSAIDs at the same time
Connect with an Ozempic provider near you to discuss how semaglutide can fit into your health regimen
BPC-157, derived from a gastric protein, is recognized for promoting angiogenesis, cellular migration, and tissue healing across various organ systems 1,2
TB4 was confirmed to drive mobilisation, migration, and differentiation of stem and progenitor cells for tissue repair and new vessel formation, while also decreasing myofibroblast numbers in wounds resulting in reduced scar formation and fibrosis
Augmentation of osseous phenotypes in vivo with a synthetic peptide